TBAJ-876
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TBAJ-876, covering 2024-10-08 to 2025-06-04. Get the full timeline:
Most recent: Clinical Trial Update: Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults [Phase 1]